EAACI Congress 2025
BackTPS54 - Allergy diagnosis 13
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
D3.63
5 Year Follow Up: Unveiling True Beta-Lactam Immediate Hypersensitivity in the University of Chile Clinical Hospital
D3.53
A retrospective audit of NSAID hypersensitivity in children and young people in a tertiary paediatric allergy centre
D3.64
Allergic diseases in children with autism spectrum disorders
D3.49
Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study
D3.58
Drug-Induced Enterocolitis Syndrome (DIES) Associated to Amoxicillin and Amoxicillin-Clavulanic Acid: A Growing Concern at a Tertiary Hospital
D3.54
Hypersensitivity reactions during therapy with platinum compounds and taxanes – who can benefit from consulting an allergist?
D3.47
Implementing Penicillin Delabelling in an Inpatient setting
D3.59
Insights from Drug Provocation Testing in Quinolone Allergy
D3.60
Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?
D3.57
Isoniazid-Induced Lupus in a Filipino Female: A Case Report
D3.50
Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists
D3.56
Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics
D3.65
Risk factors and molecular profiles of sensitization in infants with atopy in early ontogenesis
D3.55
Synthetic folic acid allergy
D3.48
The delabeling of beta-lactam allergy does not change the antibiotic prescribing profile or alerts in Primary Care. The experience of a General Hospital
D3.51
Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists
